Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial. - Wikidata - awgldk - TriplyDB

Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial.

Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial.

http://www.wikidata.org/entity/Q34847163

about

General health checks in adults for reducing morbidity and mortality from disease The Interaction Between Statins and Exercise: Mechanisms and Strategies to Counter the Musculoskeletal Side Effects of This Combination Therapy Sleep changes following statin therapy: a systematic review and meta-analysis of randomized placebo-controlled polysomnographic trials Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes Non-cardiovascular effects associated with statins Red yeast rice induces less muscle fatigue symptom than simvastatin in dyslipidemic patients: a single center randomized pilot trial.Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors Statins are related to impaired exercise capacity in males but not females.Coenzyme q10 therapy Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study.Statins, mood, sleep, and physical function: a systematic review Do statins increase and Mediterranean diet decrease the risk of breast cancer?Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?Implications of lower risk thresholds for statin treatment in primary prevention: analysis of CPRD and simulation modelling of annual cholesterol monitoring Statins and physical activity in older men: the osteoporotic fractures in men study.Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate.Communicating statin evidence to support shared decision-making.Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.Different effects of statins on induction of diabetes mellitus: an experimental study.Skeletal muscle ultrastructure and function in statin-tolerant individuals Statin use and clinical outcomes in older men: a prospective population-based study.A Systems Biology Approach to Characterize Biomarkers for Blood Stasis Syndrome of Unstable Angina Patients by Integrating MicroRNA and Messenger RNA Expression Profiling Influence of Medication on Fatigue Six Months after Stroke.MicroRNAs as biomarkers of hepatotoxicity in a randomized placebo-controlled study of simvastatin and ubiquinol supplementation.Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series Safety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: A Quasi-Experimental Study.Physicians' Experiences as Patients with Statin Side Effects: A Case Series A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins.Aggressive lipid management in very elderly adults: less is more.Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial.Excessive range of statin dose in Western Australian primary care.Lipid and other management to improve arterial disease and survival in end stage renal disease.Toxicity of Atorvastatin on Pancreas Mitochondria: A Justification for Increased Risk of Diabetes Mellitus.Treatment targets in the management of dyslipidemias: which targets in whom?Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study.Statin prescribing according to gender, age and indication: what about the benefit-risk balance?Sociodemographic and diagnostic characteristics of prescribing a second-line lipid-lowering medication: ezetimibe used as initial medication, switch from statins, or add-on medication.Coenzyme Q10 benefits symptoms in Gulf War veterans: results of a randomized double-blind study.Statin therapy, fitness, and mortality risk in middle-aged hypertensive male veterans.

P2860

Q24198193-C5DB6DC1-08DC-4030-866A-87216CD9AC28 Q26771168-3F36C392-190B-4B3F-8244-F8E07B751AE4 Q26777161-99B1B141-377F-44AB-9AFF-8F087AF6FD91 Q26853571-BD3985B1-9C13-4E70-BA75-8F22171BA4FE Q27026332-40832AB9-5982-49E5-8024-1616F3AD67C4 Q33706945-04E7459C-FDEB-41BC-AD19-832DE104A76C Q33763342-6B2F4429-C0A3-4704-AA9F-E3E8A3A6ACAD Q33803252-EC2A9726-2D35-4C52-86B7-2402A58209F6 Q33956936-B2E34F68-B1EC-43E8-9C7E-0A43986BB030 Q34451383-E0FD610F-F6CC-46E1-83E9-C776831D74E8 Q34498604-FCED7F4D-28F3-43DB-B2C1-9C65CEAC2378 Q34500694-7F23457A-74BB-47E6-B73C-3F598CE2D875 Q34536800-209B4A80-CCD3-4530-8B37-B43E8AAE5974 Q34973823-A524B8C8-5F89-4790-B34E-EBD6D5E007E7 Q35137208-C210E85C-5611-4E76-BAC1-1CCEC59D1DD8 Q35894747-F983978C-B554-4DAB-A186-047D8ECE4F71 Q35980419-55B97BEB-01A1-460C-B47C-E448808A8672 Q36200626-E91BE7A5-85F3-43C6-B628-53B2668695A5 Q36332395-6A46D0BD-0EAA-4912-A0B7-AF2EADF0A3A1 Q36355588-E9CB119B-27AD-4C2F-BC75-35D01DFDA3F4 Q36730168-A4580BDC-AE86-4999-8C6F-DE8912321052 Q36883314-8FE743F0-0E13-425F-9AA6-65EC9C914A92 Q37060065-187D149B-5DC8-4D84-9FF8-81A77BABCFD8 Q37071691-A35BAD8A-9180-41B4-AEBA-164B4D2A7186 Q37218787-13DF554A-012E-4065-B812-816ADDD8B50A Q37584425-028BB828-38CA-41C8-AFAB-502F11550C70 Q37651630-BEB57D21-C81A-41C9-A9BE-F5281993DE54 Q38113494-80F2BB42-6604-4990-A405-08904358B3DE Q38151984-960979DB-324D-4556-8B6A-4F3501A0086F Q38209732-3CACC7C0-227D-4C71-A58B-A6F3174FFFEE Q38376542-EB8BAF0D-64FB-4DD9-8E99-2301E7BB9624 Q38420257-57CC65EA-6E87-4A72-BC77-C1169CE63854 Q39097856-FB5EAC86-4592-4585-9C29-DB90DFA2680B Q39461691-1481DF8A-5B56-49D0-832E-AB0A44D2CCDC Q39556962-6D6ECC6F-A1BB-4CA8-A021-A89D2B87F630 Q39918625-64AA858F-82EA-452D-9476-20AEAE122A64 Q40455288-BF7AE3C0-580B-4513-8486-F99239E89E5E Q40677108-CBBD8ECF-D2CB-4D83-9515-4C074E64A9F2 Q45328704-28AD9744-FE5F-4799-8559-72DBE8A4393B Q45329112-D38965D8-235A-451A-A57E-534AB9902D42

P2860

Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial.

http://www.wikidata.org/entity/Q34847163

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Effects of statins on energy a ...... a randomized controlled trial.

@ast

Effects of statins on energy a ...... a randomized controlled trial.

@en

Effects of statins on energy a ...... a randomized controlled trial.

@nl

type

label

Effects of statins on energy a ...... a randomized controlled trial.

@ast

Effects of statins on energy a ...... a randomized controlled trial.

@en

Effects of statins on energy a ...... a randomized controlled trial.

@nl

prefLabel

Effects of statins on energy a ...... a randomized controlled trial.

@ast

Effects of statins on energy a ...... a randomized controlled trial.

@en

Effects of statins on energy a ...... a randomized controlled trial.

@nl

P1433

Q34847163-89E278A7-3F77-44FE-A111-2642D443BBFD

P1476

Q34847163-0F6899A5-C348-40F7-B6C0-F00D1CDCA13F

P2093

Q34847163-3FA86D13-A472-4287-9223-CB1D25C4DB24

Q34847163-BA665AAF-8560-4CFE-A71C-2A0F9EF5AAED

Q34847163-D1B16B0B-0514-43FF-80B6-9D48195212A1

Q34847163-DA0A39DB-76EB-4A57-B8C1-960B46618B73

P2860

Q34847163-33B4D43C-C2BB-4125-BC4A-27270D9C6AA1

Q34847163-54C04D4E-A60F-48BC-81CF-F391B25CA52D

Q34847163-6C1BC1E3-2BA5-46E9-9645-DBC9CF0BA431

Q34847163-91AF17A8-CD9F-45D7-9955-0D4647F0C19C

Q34847163-952E0042-AD15-4F37-87C4-6274CB595BEF

Q34847163-EA99A173-5D3B-4CD9-BF21-557F736FA20D

P304

Q34847163-2ED6479D-4D9F-4392-80ED-BB886F0DB3C6

P31

Q34847163-FCB889F2-13FB-4157-B382-05B5F5135B84

P356

Q34847163-A75E9849-5B31-4F16-8584-B46D18C5192F

P407

Q34847163-DA292FFD-0082-46A8-8695-D4A9D395B2DA

P433

Q34847163-60F45C61-CFBF-4039-B17E-DACB73526275

P478

Q34847163-FC1BE8D4-0784-4345-8105-E589D33B94A8

P577

Q34847163-B0E1B2C0-97C3-4C14-90A7-6AE259B47520

P698

Q34847163-42F331A4-A571-4877-BDF6-4DB3B7D6D172

P932

Q34847163-F05A7E76-0E48-4F27-AFE7-47088D247827

P356

ARCHINTERNMED.2012.2171

P1433

JAMA Internal Medicine

P1476

Effects of statins on energy a ...... a randomized controlled trial.

@en

P2093

Beatrice A Golomb

http://www.w3.org/2001/XMLSchema#string

Halbert L White

http://www.w3.org/2001/XMLSchema#string

Joel E Dimsdale

http://www.w3.org/2001/XMLSchema#string

Marcella A Evans

http://www.w3.org/2001/XMLSchema#string

P2860

Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism

Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems

Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.

Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial

Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.

Statin-associated muscle-related adverse effects: a case series of 354 patients.

P304

1180-1182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTERNMED.2012.2171

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

172

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22688574

http://www.w3.org/2001/XMLSchema#string

P932

4285455

http://www.w3.org/2001/XMLSchema#string